RT Journal Article
SR Electronic
T1 Field-deployable, rapid diagnostic testing of saliva samples for SARS-CoV-2
JF medRxiv
FD Cold Spring Harbor Laboratory Press
SP 2020.06.13.20129841
DO 10.1101/2020.06.13.20129841
A1 Wei, Shan
A1 Kohl, Esther
A1 Djandji, Alexandre
A1 Morgan, Stephanie
A1 Whittier, Susan
A1 Mansukhani, Mahesh
A1 Yeh, Raymond
A1 Alejaldre, Juan Carlos
A1 Fleck, Elaine
A1 Mary, D’Alton
A1 Suh, Yousin
A1 Williams, Zev
YR 2020
UL http://medrxiv.org/content/early/2020/06/16/2020.06.13.20129841.abstract
AB Rapid, scalable, point-of-need, COVID-19 diagnostic testing is necessary to safely re-open economies and prevent future outbreaks. We developed an assay that detects single copies of SARS-CoV-2 virus directly from saliva and swab samples in 30 min using a simple, one-step protocol that utilizes only a heat block and microcentrifuge tube prefilled with a mixture containing the necessary reagents and has a sensitivity and specificity of 97% and 100%, respectively.Competing Interest StatementColumbia University has filed patent applications regarding this technology.Funding StatementThis study is supported by NIH grants R01HD100013 (Z.W.), R01HD086327 (Z.W.), 1RF1AG057341 (Y.S), and R01AG057433 (Y.S).Author DeclarationsI confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.YesThe details of the IRB/oversight body that provided approval or exemption for the research described are given below:This portion of our study was reviewed and approved by the Columbia University IRB (#AAAS9893) and all methods were carried out in accordance with relevant guidelines and regulations. All study subjects signed informed consent prior to participating.All necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived.YesI understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).YesI have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.YesNo sequencing data was generated in this study.